Nigeria: Nigeria Now! Opens Its Project Boardrooms to Global Investors in Abuja

What the report says
Nigeria is preparing to host Nigeria NOW! in Abuja on 19 and 20 November, according to Premium Times reporting distributed by AllAfrica. The event will take place at the Bola Ahmed Tinubu International Conference Centre and is being held under the patronage of the Minister of Solid Minerals Development, Dr Oladele Henry Alake, who will serve as chief host.
The programme is designed to present investment opportunities across mining, energy, transport and related infrastructure. The report says the government will use investor boardrooms to review projects in detail, including mineral processing plans, power-sector support for industrial hubs, transport and port projects, and a domestic green bond. It also highlights a separate youth-focused track, YES! Nigeria, scheduled for the second day.
The article links the conference to a broader push by the federal government to attract capital into Nigeria’s resource and infrastructure sectors. It says annual mining revenue has risen sharply in recent years, and that new projects in lithium and rare earth processing are already under way or being planned. The report also notes that mining lease applicants must now include value-addition plans, signaling a stronger emphasis on domestic processing rather than raw exports.
Premium Times also cited support from partners including the Lagos State Government and several industry and civil-society groups. For investors, the event is intended as a venue to assess bankable projects and policy changes as Nigeria seeks to position its minerals and infrastructure sectors for more foreign participation.
Loading debate for this article…
Other publishers covering this story
No additional verified coverage is currently clustered with this report.

Argentinian judge drops fraud investigation into Milei over crypto scandalAl Jazeera
Syrians protest Israel’s incursions near occupied Golan HeightsAl Jazeera
WHO announces start of Ebola vaccine clinical trial in DR CongoAl Jazeera